Catalent R&D Director Appointed To Alsace BioValley Board of Directors

Online, October 4, 2010 (Newswire.com) - Somerset, NJ - Julien Meissonnier, Director of R&D for Catalent Pharma Solutions in Beinheim, France, has been appointed to the Board of Directors of the Alsace BioValley, the cluster for life sciences and healthcare in France. BioValley is a unique tri-national network of French, Swiss and German contributors, serving as a gateway to biobusiness development in Europe by bringing together and supporting the collaboration of public and private enterprises. As a board member, Mr. Meissonnier will work to support Alsace BioValley in its efforts to continue driving growth in the life sciences by identifying and coordinating ambitious projects that will create employment opportunities in the region.

"I am pleased to join a team of individuals committed to growing the life sciences in the BioValley area. It is an honor to be recognized, and at Catalent, we are passionate about innovation and growth. It is exciting to contribute to this culture within the BioValley team," said Mr. Meissonnier.

Francois Boçquel, President of Alsace BioValley, said, "It is with enthusiasm that we welcome Julien Meissonnier to our Board of Directors. The opportunity for growth in the life sciences within this region is significant. We benefit from first-class academic research, a remarkable capacity for training and a critical mass of leading industries. Directing this organization is a tremendous responsibility and we look forward to Julien's contribution."

At Catalent, Mr. Meissonnier provides technical and scientific leadership for the development of delivery systems for poorly soluble drugs that lead to approvable regulatory dossiers. His responsibilities include early stage screening activities, developing products, scale-up and technology transfer, directing clinical supplies and supporting product launches. Mr. Meissonnier has 12 years of experience in pharmaceutical development. He received his Engineer Degree in Physico-Chemistry from the ENSI in Caen, France.

For more information, please contact Mr. Meissonnier at [email protected]

About Catalent
Headquartered in Somerset, New Jersey, Catalent is one of the leading providers of advanced dose form and packaging technologies, and development, manufacturing, packaging and printing services for pharmaceutical, biotechnology and consumer healthcare companies in nearly 100 countries. Catalent applies its local market expertise and technical creativity to advance treatments, change markets and enhance patient outcomes. Catalent employs approximately 9,000 at 30 facilities worldwide and in fiscal 2010 generated more than $1.7 billion of annual revenue. For more information, visit www.catalent.com.

For more information on Alsace Biovalley, visit www.alsace-biovalley.com.